Quanta, Inc. (QNTA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Quanta, Inc. (QNTA) with AI Score 50/100 (Hold). Quanta, Inc. is an applied science company focused on developing and distributing pharmaceutical, nutraceutical, topical relief, and cosmetic products. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 18, 2026Quanta, Inc. (QNTA) Consumer Business Overview
Quanta, Inc. operates in the consumer wellness sector, providing pharmaceutical-grade products, clinical evidence-based nutraceuticals, and contract research services. The company utilizes patented polarization technology in its offerings, targeting pain relief, beauty, and general wellness markets, while facing competition from established players.
Investment Thesis
Quanta, Inc. presents a high-risk, high-reward investment opportunity within the consumer wellness sector. The company's reliance on patented polarization technology and contract research services could drive growth if successfully commercialized. However, the company's negative profit margin of -1312.4% and small market capitalization of $0.00B highlight significant financial challenges. Key value drivers include successful product development and market penetration in the pain relief, beauty, and general wellness categories. Upcoming catalysts involve securing additional contract research agreements and expanding distribution channels. Potential risks include intense competition, limited financial resources, and the need for further clinical validation of its technology. Investors should carefully consider the company's financial position and execution risks before investing.
Based on FMP financials and quantitative analysis
Key Highlights
- Gross Margin of 78.7% indicates strong potential for profitability if sales volume increases.
- Negative Profit Margin of -1312.4% reflects significant operational losses and the need for improved cost management.
- Market Cap of $0.00B signifies a micro-cap company with high growth potential but also high risk.
- The company's Beta of 1.68 suggests higher volatility compared to the overall market.
- Founded in 2016, Quanta is a relatively young company in the competitive consumer wellness market.
Competitors & Peers
Strengths
- Patented polarization technology.
- Contract research service offerings.
- Focus on pharmaceutical-grade products.
- Potential for innovation in the consumer wellness market.
Weaknesses
- Small company size with limited resources.
- Negative profit margin and financial instability.
- Limited brand recognition and market presence.
- Reliance on a small number of employees.
Catalysts
- Upcoming: Potential new contract research agreements with pharmaceutical or nutraceutical companies.
- Upcoming: Launch of new consumer wellness products utilizing patented polarization technology.
- Ongoing: Expansion of e-commerce platform and direct-to-consumer sales.
- Ongoing: Exploration of strategic partnerships with established distributors and retailers.
Risks
- Potential: Intense competition from larger, more established companies in the consumer wellness market.
- Potential: Limited financial resources and the need for additional funding.
- Potential: Regulatory hurdles and compliance requirements for pharmaceutical and nutraceutical products.
- Ongoing: Negative profit margin and financial instability.
- Ongoing: Dependence on patented polarization technology and the risk of technological obsolescence.
Growth Opportunities
- Expansion of Contract Research Services: Quanta can leverage its research and development capabilities to secure additional contract research agreements with pharmaceutical and nutraceutical companies. The global contract research organization (CRO) market is projected to reach $79.3 billion by 2027, offering significant growth potential for Quanta. Timeline: Ongoing.
- Product Line Expansion: Quanta can introduce new products within the pain relief, beauty, and general wellness categories, leveraging its patented polarization technology. The global pain relief market is expected to reach $11.3 billion by 2028. Successful product launches can drive revenue growth and market share gains. Timeline: 1-2 years.
- Strategic Partnerships: Quanta can form strategic partnerships with established distributors and retailers to expand its market reach and distribution channels. Collaborations with major retailers can provide access to a wider customer base and increase brand visibility. Timeline: Ongoing.
- E-commerce Channel Development: Quanta can invest in its e-commerce platform to drive direct-to-consumer sales and improve customer engagement. The global e-commerce market is experiencing rapid growth, providing opportunities for Quanta to expand its online presence and reach new customers. Timeline: 6-12 months.
- International Market Expansion: Quanta can explore opportunities to expand its operations into international markets, particularly in regions with growing demand for consumer wellness products. Entering new markets can diversify revenue streams and reduce reliance on the domestic market. Timeline: 2-3 years.
Opportunities
- Expansion of contract research services.
- New product development and market penetration.
- Strategic partnerships with established distributors.
- Growth in the consumer wellness market.
Threats
- Intense competition from larger companies.
- Regulatory hurdles and compliance requirements.
- Economic downturn and reduced consumer spending.
- Technological obsolescence.
Competitive Advantages
- Patented Polarization Technology: Provides a unique selling proposition and potential competitive advantage.
- Contract Research Services: Offers a diversified revenue stream and opportunities for collaboration.
- Focus on Pharmaceutical-Grade Products: Targets a higher-margin segment of the consumer wellness market.
About QNTA
Founded in 2016 and headquartered in Burbank, California, Quanta, Inc. is an applied science company focused on the development, production, and distribution of consumer wellness products. The company operates within the household and personal products industry, offering a range of pharmaceutical, nutraceutical, topical relief, and cosmetic products. Quanta's business model encompasses contract research services, including research, development, and production of pharmaceutical-grade products, as well as clinical evidence-based nutraceuticals utilizing patented polarization technology. Quanta manufactures and distributes consumer wellness products targeting pain relief, beauty, and general wellness. The company's patented polarization technology is a key differentiator in its nutraceutical offerings. While relatively young, Quanta seeks to establish itself through innovation and contract research services, aiming to capture market share in the competitive consumer wellness landscape. The company's small size, with only 4 employees, indicates an early stage of development and a focus on leveraging its technology and research capabilities.
What They Do
- Develops pharmaceutical-grade products.
- Creates clinical evidence-based nutraceuticals.
- Manufactures topical relief products.
- Produces cosmetic products.
- Offers contract research services to other companies.
- Utilizes patented polarization technology in its products.
- Distributes consumer wellness products.
Business Model
- Generates revenue through the sale of pharmaceutical, nutraceutical, topical relief, and cosmetic products.
- Earns income from contract research services provided to other companies.
- Utilizes patented polarization technology to create differentiated products.
- Focuses on the consumer wellness market.
Industry Context
Quanta, Inc. operates in the competitive household and personal products industry, which is characterized by established players and evolving consumer preferences. The global wellness market is experiencing growth, driven by increased health awareness and demand for natural and innovative products. Quanta's focus on pharmaceutical-grade products and patented polarization technology positions it within the higher-margin segments of the market. However, the company faces competition from larger, more established companies with greater resources and brand recognition. Key trends include personalized wellness solutions and e-commerce distribution.
Key Customers
- Consumers seeking pain relief products.
- Individuals interested in beauty and cosmetic products.
- Customers looking for general wellness solutions.
- Pharmaceutical and nutraceutical companies seeking contract research services.
Financials
Chart & Info
Quanta, Inc. (QNTA) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Wednesday
· Sep 25, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for QNTA.
Price Targets
Wall Street price target analysis for QNTA.
MoonshotScore
What does this score mean?
The MoonshotScore rates QNTA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Arthur G. Mikaelian
CEO
Arthur G. Mikaelian serves as the CEO of Quanta, Inc., leading a small team of 4 employees. Information regarding his detailed career history and educational background is not available in the provided data. However, as CEO, he is responsible for the overall strategic direction and operational management of the company, focusing on the development and commercialization of Quanta's pharmaceutical, nutraceutical, and cosmetic products.
Track Record: Due to the limited information available, Arthur G. Mikaelian's track record at Quanta, Inc. cannot be comprehensively assessed. However, as the CEO since 2016, he has overseen the company's development and launch of products utilizing patented polarization technology. Further information is needed to evaluate his specific achievements and strategic decisions.
QNTA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Quanta, Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to greater regulatory scrutiny. Trading on the OTC Other tier carries higher risks compared to exchanges like the NYSE or NASDAQ due to less stringent listing standards and potentially lower liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for price manipulation and fraud.
- Higher risk of delisting or trading suspension.
- Lower liquidity and wider bid-ask spreads.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and technology.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Patented polarization technology.
- Contract research service offerings.
- Focus on pharmaceutical-grade products.
- Headquartered in Burbank, California.
Common Questions About QNTA
What does Quanta, Inc. do?
Quanta, Inc. is an applied science company that develops, manufactures, and distributes pharmaceutical, nutraceutical, topical relief, and cosmetic products. The company also offers contract research services, leveraging its patented polarization technology. Its products target the consumer wellness market, focusing on areas such as pain relief, beauty, and general well-being. Quanta aims to differentiate itself through its innovative technology and research capabilities within the competitive household and personal products industry.
What do analysts say about QNTA stock?
As of 2026-03-18, there is no available analyst coverage or consensus for QNTA stock. The company's small market capitalization and OTC listing may contribute to the lack of analyst coverage. Investors should conduct their own due diligence and consider the company's financial position, growth potential, and risk factors before making any investment decisions. Key valuation metrics such as P/E ratio and dividend yield are not applicable due to the company's negative earnings and lack of dividend payments.
What are the main risks for QNTA?
Quanta, Inc. faces several key risks, including intense competition from larger, more established companies in the consumer wellness market. The company's limited financial resources and negative profit margin pose significant challenges to its long-term sustainability. Regulatory hurdles and compliance requirements for pharmaceutical and nutraceutical products also present risks. Additionally, the company's dependence on patented polarization technology exposes it to the risk of technological obsolescence. Investors should carefully consider these risks before investing in QNTA.
What are the key factors to evaluate for QNTA?
Quanta, Inc. (QNTA) currently holds an AI score of 50/100, indicating moderate score. Key strength: Patented polarization technology.. Primary risk to monitor: Potential: Intense competition from larger, more established companies in the consumer wellness market.. This is not financial advice.
How frequently does QNTA data refresh on this page?
QNTA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven QNTA's recent stock price performance?
Recent price movement in Quanta, Inc. (QNTA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patented polarization technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider QNTA overvalued or undervalued right now?
Determining whether Quanta, Inc. (QNTA) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying QNTA?
Before investing in Quanta, Inc. (QNTA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC listing and small market capitalization increase investment risk.
- Lack of analyst coverage and consensus.